Information
About Zocor
IMPORTANT NOTE: The following
information is intended to supplement, not substitute
for, the expertise and judgment of your physician,
pharmacist or other healthcare professional. It should
not be construed to indicate that use of the drug
is safe, appropriate, or effective for you. Consult
your healthcare professional before using this drug.
How To Use
Follow the directions for using Zocor provided by
your doctor. Zocor may not be used for some people.
Discuss with your doctor if Zocor is right for you.
Follow the directions for using Zocor provided by
your doctor.
Side Effects
Side effects may occur from Zocor treatment including
gas, stomach pain or cramps, diarrhea, constipation,
heartburn, headache, blurred vision, dizziness, rash
or itching and upset stomache. Although most patients
can tolerate treatment with Zocor well, Zocor may
cause side effects, some of which could be serious.
Side effects are usually mild and short-lived. Your
doctor should weigh the benefits/risks balance before
prescribing Zocor. In clinical studies with Zocor,
less than 1.5% of probands dropped out of the studies
due to side effects. In a large, long-term study,
patients taking Zocor experienced side effects similar
to those of the patients taking placebo (sugar pills).
Some of the side effects that have been reported with
Zocor are listed below. This list is not complete.
Ask your doctor about possible side effects before
taking Zocor.
Digestive System: Constipation,
diarrhea, upset stomach, gas, heartburn, stomach pain/cramps,
anorexia, loss of appetite, nausea, inflammation of
the pancreas, hepatitis, jaundice, fatty changes in
the liver, and, rarely, severe liver damage and failure,
cirrhosis, and liver cancer.
Muscle, Skeletal: Muscle cramps, aches,
pain, and weakness; joint pain; muscle breakdown.
Nervous System: Dizziness, headache,
insomnia, tingling, memory loss, damage to nerves
causing weakness and/or loss of sensation and/or abnormal
sensations, anxiety, depression, tremor, loss of balance,
psychic disturbances.
Skin: Rash, itching, hair loss, dryness,
nodules, discoloration.
Eye/Senses: Blurred vision, altered
taste sensation, progression of cataracts, eye muscle
weakness.
Hypersensitivity (Allergic) Reactions:
On rare occasions, a wide variety of symptoms have
been reported to occur either alone or together in
groups (referred to as a syndrome) that appeared to
be based on allergic-type reactions, which may rarely
be fatal. These have included one or more of the following:
a severe generalized reaction that may include shortness
of breath, wheezing, digestive symptoms, and low blood
pressure and even shock; an allergic reaction with
swelling of the face, lips, tongue and/or throat with
difficulty swallowing or breathing; symptoms mimicking
lupus (a disorder in which a person's immune system
may attack parts of his or her own body); severe muscle
and blood vessel inflammation; bruises; various disorders
of blood cells (that could result in anemia, infection,
or blood clotting problems) or abnormal blood tests;
inflamed or painful joints; hives; fatigue and weakness;
sensitivity to sunlight; fever, chills; flushing;
difficulty breathing; and severe skin disorders that
vary from rash to a serious burn-like shedding of
skin all over the body, including mucous membranes
such as the lining of the mouth.
Other: Loss of sexual desire, breast
enlargement, impotence.
Laboratory Tests: Liver function test
abnormalities including elevated alkaline phosphatase
and bilirubin; thyroid function abnormalities.
Precautions and Drug Interactions
About 1% of patients who took Zocor in clinical trials
developed elevated levels of some liver enzymes. Patients
who had these increases usually had no symptoms. Elevated
liver enzymes usually returned to normal levels when
Zocor was stopped. In the Zocor Survival Study, the
number of patients with more than one liver enzyme
level elevation to greater than 3 times the normal
upper limit was not noticeably different between the
Zocor and placebo groups. Only 8 patients on Zocor
and 5 on placebo discontinued therapy due to elevated
liver enzyme levels. Your doctor should perform routine
blood tests to check these enzymes before you start
treatment with Zocor and periodically thereafter,
for example, semiannually, for your first year of
treatment or until one year after your last elevation
in dose. If your enzyme levels increase, your doctor
should order more frequent tests. If your liver enzyme
levels remain unusually high, your doctor may discontinue
your medication. Tell your doctor about any liver
disease you may have had in the past and about how
much alcohol you consume. Zocor should be used with
caution in patients who consume large amounts of alcohol.
Muscle: Tell your doctor immediately if you experience
any muscle pain, tenderness, or weakness at any time
during treatment with Zocor, particularly if you have
a fever or if you are generally not feeling well.
Some patients may have muscle pain or weakness while
taking Zocor. Rarely, this can include muscle breakdown
resulting in kidney damage. The risk of muscle breakdown
is greater in patients taking certain other drugs
along with Zocor, such as the lipid-lowering drug
Lopid (gemfibrozil), lipid-lowering doses of nicotinic
acid (niacin), the antibiotics erythromycin and clarithromycin,
nefazodone, antifungal drugs that are azole derivatives,
such as itraconazole and ketoconazole, the calcium
channel blocker Posicor, or drugs that suppress the
immune system (called immunosuppressive drugs, such
as Sandimmune [cyclosporine]). Patients using Zocor
along with any of these other drugs should be carefully
monitored by their physician. If you have conditions
that can increase your risk of muscle breakdown, which
in turn can cause kidney damage, your doctor should
temporarily withhold or stop Zocor. Such conditions
include severe infection, low blood pressure, major
surgery, trauma, severe metabolic, endocrine and electrolyte
disorders, and uncontrolled seizures. Also, since
there are no known adverse consequences of briefly
stopping therapy with Zocor, treatment should be stopped
a few days before elective major surgery. Discuss
this with your doctor, who can explain these conditions
to you. Because there are risks in combining therapy
with Zocor with lipid-lowering doses of nicotinic
acid (niacin) or with drugs that suppress the immune
system, your doctor should carefully weigh the potential
benefits and risks. He or she should also carefully
monitor patients for any muscle pain, tenderness,
or weakness, particularly during the initial months
of therapy and if the dose of either drug is increased.
Your doctor may also monitor the level of certain
muscle enzymes in your body, but there is no assurance
that such monitoring will prevent the occurrence of
severe muscle disease.
Warning
Before starting treatment with Zocor, try to lower
your cholesterol by other methods such as diet, exercise,
and weight loss. Ask your doctor about how best to
do this. Any other medical problems that can cause
high cholesterol should also be treated. Zocor is
less effective in patients with the rare disorder
known as homozygous familial hypercholesterolemia.
Drug Interactions: Because of possible serious drug
interactions, it is important to tell your doctor
what other drugs you are taking, including those obtained
without a prescription.
Zocor can interact with Posicor, Lopid, niacin, erythromycin,
clarithromycin, nefazodone, certain antifungal drugs,
and drugs that suppress the immune system (called
immunosuppressive drugs, such as Sandimmune). (See
WARNINGS, Muscle.)
Some patients taking lipid-lowering agents similar
to Zocor and coumarin anticoagulants (a type of blood
thinner) have experienced bleeding and/or increased
blood clotting time. Patients taking these medicines
should have their blood tested before starting therapy
with Zocor and should continue to be monitored.
Endocrine (Hormone) Function: Zocor and other drugs
in this class may affect the production of certain
hormones. Caution should be exercised if a drug used
to lower cholesterol levels is administered to patients
also receiving other drugs (e.g., ketoconazole, spironolactone,
cimetidine) that may decrease the levels or activity
of hormones. If you are taking any such drugs, tell
your doctor.
Central Nervous System Toxicity; Cancer, Mutations,
Impairment of Fertility: Like most prescription drugs,
Zocor was required to be tested on animals before
it was marketed for human use. Often these tests were
designed to achieve higher drug concentrations than
humans achieve at recommended dosing. In some tests,
the animals had damage to the nerves in the central
nervous system. In studies of mice with high doses
of Zocor, the likelihood of certain types of cancerous
tumors increased. No evidence of mutations of or damage
to genetic material has been seen. In one study with
Zocor, there was decreased fertility in male rats.
Pregnancy: Pregnant women should not take Zocor because
it may harm the fetus.
Safety in pregnancy has not been established. In studies
with lipid-lowering agents similar to Zocor, there
have been rare reports of birth defects of the skeleton
and digestive system. Therefore, women of childbearing
age should not take Zocor unless it is highly unlikely
they will become pregnant. If a woman does become
pregnant while taking Zocor, she should stop taking
the drug and talk to her doctor at once. The active
ingredient of Zocor did not cause birth defects in
rats at 6 times the human dose or in rabbits at 4
times the human dose.
Nursing Mothers: Drugs taken by nursing mothers may
be present in their breast milk. Because of the potential
for serious adverse reactions in nursing infants,
a woman taking Zocor should not breast-feed. (See
WHEN Zocor SHOULD NOT BE USED.)
Pediatric Use: Zocor is not recommended for children
or patients under 20 years of age.
Overdose
If overdose is suspected, contact your local poison
control center or emergency room immediately.
NOTES: Do not share this Zocor
with others.
MISSED DOSE: If you miss a dose,
take it as soon as remembered; do not take it if it
is near the time for the next dose, instead, skip
the missed dose and resume your usual dosing schedule.
Do not double the dose to catch up.
STORAGE: Store this medication
at room temperature between 59 and 86 degrees F (15
to 30 degrees C) away from heat and light. Do not
store in the bathroom. Keep this and all medications
out of the reach of children.
|